| 摘要 |
[Problem] To verify an advantage in terms of hepatic fibrosis-ameliorating effect in hepatitis/hepatic cirrhosis using a thioacetamide hepatic dysfunction model, and provide this advantage. [Solution] This advantage is achieved by means of a compounding agent that includes zinc and selenium. |
